Viatris (VTRS) Amortization of Goodwill (2023 - 2025)

Viatris (VTRS) recorded quarterly Amortization of Goodwill of $2.9 billion in Q1 2025, up 815.89% quarter-over-quarter from $321.0 million in Q2 2024.

Viatris (VTRS) Amortization of Goodwill (2023 - 2025) Analysis & Trends

Viatris' Amortization of Goodwill history runs 3 years deep, the most recent figure standing at $2.9 billion for Q1 2025.

  • In Q1 2025, Amortization of Goodwill changed N/A year-over-year to $2.9 billion; the TTM figure through Dec 2025 stood at $2.9 billion (up 815.89% YoY), while the FY2025 annual figure was $2.9 billion, up 814.89% from the prior year.
  • Amortization of Goodwill was $2.9 billion for Q1 2025 at Viatris, up from $321.0 million in the prior quarter.
  • In the past five years, Amortization of Goodwill ranged from a high of $2.9 billion in Q1 2025 to a low of $321.0 million in Q2 2024.
  • Historically, Amortization of Goodwill has averaged $1.3 billion across 3 years, with a median of $580.1 million in 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Viatris - - 1.16 Bn

Historic Data

Download Data
DateValue
Mar 31, 2025 2.94 Bn
Mar 31, 2025 2.94 Bn
Jun 30, 2024 321.00 Mn
Jun 30, 2024 321.00 Mn
Dec 31, 2023 580.10 Mn
Dec 31, 2023 580.10 Mn